Oncopeptides
2,07 SEK -12,66%1 investor følger denne virksomhed
Oncopeptides is a biotech company that develops drugs for difficult-to-treat hematological diseases. The company uses its PDC platform to develop peptide-linked drugs that selectively deliver cytotoxic drugs into cancer cells. The company has drugs in commercialization and several drug candidates under development. Oncopeptide's head office is located in Stockholm.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
ONCO
Daglig lav / høj pris
1,998 / 2,54
SEK
Markedsværdi
445,44 mio. SEK
Aktieomsætning
6,91 mio. SEK
Volumen
3,2 mio.
Seneste videoer
Finanskalender
Delårsrapport
14.08.2024
Delårsrapport
07.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
HealthCap VIII L.P. | 12,7 % | 12,9 % |
Avanza Pension | 7,9 % | 8,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Oncopeptides publishes Q2 report 2024
Invitation to presentation of the Q2 report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools